Status:
UNKNOWN
Usability of Ringed Polytetrafluoroethylene Graft for Venous Vascular Reconstruction of Living Donor Liver Transplantation
Lead Sponsor:
Asan Medical Center
Conditions:
Patency, Hepatic Venous Congestion
Eligibility:
All Genders
Phase:
PHASE2
PHASE3
Brief Summary
Middle hepatic vein (MHV) reconstruction with an interposition vessel graft has been settled as a standard procedure for living donor liver transplantation (LDLT) using a right lobe graft. Increasing ...
Detailed Description
Since late 2009, the relative supply of vessel allograft over the increasing demand on LDLT became seriously shortened in the investigators' institution. Thus the investigators decide to use prostheti...
Eligibility Criteria
Inclusion
- Living donor liver transplantation requiring MHV reconstruction
Exclusion
- Living donor liver transplantation not requiring MHV reconstruction
Key Trial Info
Start Date :
August 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2012
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT01205802
Start Date
August 1 2010
End Date
July 1 2012
Last Update
September 21 2010
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Asan Medical Center
Seoul, Seoul, South Korea, 138-736